by Rob Blaich | Jun 9, 2020 | DND News
A paper titled, “A review of clinical treatment considerations of donepezil in severe Alzheimer’s disease” authored by Dr. Aida Adlimoghaddam, postdoctoral fellow, and Dr. Benedict C. Albensi, Principal Investigator Synaptic Plasticity and Cellular Memory Dysfunction...
by Rob Blaich | May 19, 2020 | DND News
Dr. Benedict C. Albensi, Principal Investigator, Synaptic Plasticity and Cellular Memory Dysfunction Lab, Division of Neurodegenerative Disorders will be hosting a seminar on Brain Injury and Dementia via Zoom, May 22, 2020, at 6:30 PM CST. Zoom Webinar – Brain...
by Rob Blaich | Apr 17, 2020 | DND News
Kudos to Dr. Benedict Albensi, Principal Investigator Synaptic Plasticity and Cellular Memory Dysfunction Lab, Division of Neurodegenerative Disorders, who has been extremely busy doing several online interviews, podcasts and seminars recently. Links available below:...
by Karen Hiebert | Feb 20, 2020 | DND News, Home News
Congratulations to Dr. Benedict Albensi, Principal Investigator, St. Boniface Hospital Research, Division of Neurodegenerative Disorders (DND); Professor & Manitoba Dementia Research Chair, Max Rady College of Medicine, Dept. of Pharmacology & Therapeutics,...
by Karen Hiebert | Jun 21, 2019 | CCARM News, DND News, Home News
Bradley Feltham, CCARM Research Assistant, was recently recognized as an outstanding undergraduate student in the Faculty of Agriculture and Food Sciences at U of M, and in-turn, he formally recognized his supervisor, Dr. Miyoung Suh, for teaching excellence at the...
by Karen Hiebert | Jun 21, 2019 | DND News, Home News
Congratulations to Dr. Ben Albensi, one of five Manitoba-based researchers collaborating with 300 other Canadian scientists on 19 research teams to help prevent, treat and cure age-related neurodegenerative diseases. The government of Canada recently announced an...
